Protein profile

PA3257

tail-specific protease

Genome: NC_002516.2

Gene: prc PA3257 Structure source: AlphaFold UniProt Q9HYY3
Amino acids 698
Annotations 6
Features 43
PDB binders 1
Druggability 0.623

Overview

Basic information about this protein and its source genome.

Accession
PA3257
Gene
prc PA3257
Status
annotated
Amino acids
698
Structure source
AlphaFold
GO
GO:0030288 The region between the inner (cytoplasmic or plasma) membrane and outer membrane of organisms with two membranes such as Gram negative bacteria. These periplasmic spaces are relatively thick and contain a thin peptidoglycan layer (PGL), also referred to as a thin cell wall. GO:0004175 Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain. GO:0008236 Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine). GO:0006508 The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. GO:0007165 The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. GO:0005515 Binding to a protein.

Target profile

Computed evidence for target prioritization.

Human off-target
No hit
Gut microbiome off-target
hit
Essential (DEG)
Y
Localization
CytoplasmicMembrane

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.623
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

6 GO

Gene Ontology (GO)

6
  • GO:0030288 The region between the inner (cytoplasmic or plasma) membrane and outer membrane of organisms with two membranes such as Gram negative bacteria. These periplasmic spaces are relatively thick and contain a thin peptidoglycan layer (PGL), also referred to as a thin cell wall.
  • GO:0004175 Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
  • GO:0008236 Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
  • GO:0006508 The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
  • GO:0007165 The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
  • GO:0005515 Binding to a protein.

Sequence Features

Domain/signature hits from InterPro and related databases.

43 records
Show feature table
Start End DB Term Name
8 23 Phobius SIGNAL_PEPTIDE_H_REGION Hydrophobic region of a signal peptide.
1 7 Phobius SIGNAL_PEPTIDE_N_REGION N-terminal region of a signal peptide.
253 330 SMART SM00228 pdz_new
253 330 InterPro IPR001478 PDZ domain
606 640 Coils Coil Coil
253 350 Gene3D G3DSA:2.30.42.10 -
253 350 InterPro IPR036034 PDZ superfamily
24 32 Phobius SIGNAL_PEPTIDE_C_REGION C-terminal region of a signal peptide.
244 328 SUPERFAMILY SSF50156 PDZ domain-like
244 328 InterPro IPR036034 PDZ superfamily
646 676 MobiDBLite mobidb-lite consensus disorder prediction
1 25 SignalP_EUK SignalP-noTM SignalP-noTM
252 337 CDD cd00988 PDZ_CTP_protease
210 565 NCBIfam TIGR00225 C-terminal processing peptidase
210 565 InterPro IPR004447 C-terminal-processing peptidase S41A
336 545 SMART SM00245 tsp_4
336 545 InterPro IPR005151 Tail specific protease
188 549 SUPERFAMILY SSF52096 ClpP/crotonase
188 549 InterPro IPR029045 ClpP/crotonase-like domain superfamily
176 262 FunFam G3DSA:3.30.750.44:FF:000007 Periplasmic tail-specific protease
52 239 Pfam PF17804 Tail specific protease N-terminal domain
52 239 InterPro IPR040573 Tail specific protease, N-terminal domain
370 543 Pfam PF03572 Peptidase family S41
370 543 InterPro IPR005151 Tail specific protease
33 698 Phobius NON_CYTOPLASMIC_DOMAIN Region of a membrane-bound protein predicted to be outside the membrane, in the extracellular region.
253 350 FunFam G3DSA:2.30.42.10:FF:000162 Tail-specific protease
370 542 CDD cd07560 Peptidase_S41_CPP
370 542 InterPro IPR004447 C-terminal-processing peptidase S41A
351 542 Gene3D G3DSA:3.90.226.10 -
1 32 Phobius SIGNAL_PEPTIDE Signal peptide region
549 689 Pfam PF11818 C-terminal domain of tail specific protease (DUF3340)
549 689 InterPro IPR020992 Tail specific protease, C-terminal
1 23 SignalP_GRAM_NEGATIVE SignalP-noTM SignalP-noTM
335 564 FunFam G3DSA:3.90.226.10:FF:000090 Tail-specific protease
195 215 Coils Coil Coil
177 520 Gene3D G3DSA:3.30.750.44 -
246 326 Pfam PF00595 PDZ domain
246 326 InterPro IPR001478 PDZ domain
641 677 MobiDBLite mobidb-lite consensus disorder prediction
157 568 PANTHER PTHR32060 TAIL-SPECIFIC PROTEASE
1 32 SignalP_GRAM_POSITIVE SignalP-TM SignalP-TM
245 315 ProSiteProfiles PS50106 PDZ domain profile.
245 315 InterPro IPR001478 PDZ domain

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold PA3257
AlphaFold full sequence Viewing
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
3 0.623
7 0.233

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

1 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
TMO A0A1E3M7A1 75.1 Da LogP 0.19 TPSA 23.1 ✓ Ro5 ✓ Clean C[N+](C)(C)[O-]

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.